BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med. 1995;333:32-41. [PMID: 7776992 DOI: 10.1056/nejm199507063330107] [Cited by in Crossref: 453] [Cited by in F6Publishing: 132] [Article Influence: 17.4] [Reference Citation Analysis]
Number Citing Articles
1 Song HR, Shin MH, Kim HN, Piao JM, Choi JS, Hwang JE, Park YK, Ryang DW, Cho D, Kweon SS. Sex-specific differences in the association between ABO genotype and gastric cancer risk in a Korean population. Gastric Cancer 2013;16:254-60. [PMID: 22865192 DOI: 10.1007/s10120-012-0176-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
2 Chuwa EW, Khin LW, Chan WH, Ong HS, Wong WK. Prognostic significance of peritoneal lavage cytology in gastric cancer in Singapore. Gastric Cancer. 2005;8:228-237. [PMID: 16328597 DOI: 10.1007/s10120-005-0343-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
3 Enzinger PC, Benedetti JK, Meyerhardt JA, McCoy S, Hundahl SA, Macdonald JS, Fuchs CS. Impact of hospital volume on recurrence and survival after surgery for gastric cancer. Ann Surg. 2007;245:426-434. [PMID: 17435550 DOI: 10.1097/01.sla.0000245469.35088.42] [Cited by in Crossref: 66] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
4 Shi X, Li X, Chen L, Wang C. Analysis of somatostatin receptors and somatostatin promoter methylation in human gastric cancer. Oncol Lett 2013;6:1794-8. [PMID: 24260078 DOI: 10.3892/ol.2013.1614] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
5 Cooke CL, Torres J, Solnick JV. Biomarkers of Helicobacter pylori-associated gastric cancer. Gut Microbes. 2013;4:532-540. [PMID: 23851317 DOI: 10.4161/gmic.25720] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
6 Phan AT, Ajani JA. Gastric carcinoma. Curr Oncol Rep 2004;6:192-8. [PMID: 15066230 DOI: 10.1007/s11912-004-0049-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
7 Liou JM, Lin JT, Huang SP, Wu CY, Wang HP, Lee YC, Chiu HM, Shun CT, Lin MT, Wu MS. RANTES-403 polymorphism is associated with reduced risk of gastric cancer in women. J Gastroenterol 2008;43:115-23. [PMID: 18306985 DOI: 10.1007/s00535-007-2136-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
8 Ge W, Chen G, Fan XS. Pathway of peritoneal carcinomatosis maybe hematogenous metastasis rather than peritoneal seeding. Oncotarget 2017;8:41549-54. [PMID: 28099909 DOI: 10.18632/oncotarget.14607] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
9 Kim DY, Cho MH, Yang HK, Hemminki K, Kim JP, Jang JJ, Kumar R. Detection of methylation damage in DNA of gastric cancer tissues using 32P postlabelling assay. Jpn J Cancer Res. 1999;90:1104-1108. [PMID: 10595739 DOI: 10.1111/j.1349-7006.1999.tb00684.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
10 Weledji EP, Enow Orock G, Ngowe MN. Intestinal metaplasia and anastomotic recurrence of gastric carcinoma. J Gastrointest Oncol 2014;5:474-80. [PMID: 25436128 DOI: 10.3978/j.issn.2078-6891.2014.048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Lee JH, Bae JS, Ryu KW, Lee JS, Park SR, Kim CG, Kook MC, Choi IJ, Kim YW, Park JG. Gastric cancer patients at high-risk of having synchronous cancer. World J Gastroenterol. 2006;12:2588-2592. [PMID: 16688807 DOI: 10.3748/wjg.v12.i16.2588] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
12 McClain MS, Shaffer CL, Israel DA, Peek RM Jr, Cover TL. Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer. BMC Genomics 2009;10:3. [PMID: 19123947 DOI: 10.1186/1471-2164-10-3] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 6.5] [Reference Citation Analysis]
13 Jácome AA, Coutinho AK, Lima EM, Andrade AC, Dos Santos JS. Personalized medicine in gastric cancer: Where are we and where are we going? World J Gastroenterol. 2016;22:1160-1171. [PMID: 26811654 DOI: 10.3748/wjg.v22.i3.1160] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
14 Cao Y, Liu H, Zhang H, Lin C, Li R, Zhang W, Shen Z, Xu J. Decreased expression of Siglec-8 associates with poor prognosis in patients with gastric cancer after surgical resection. Tumour Biol 2016;37:10883-91. [PMID: 26883254 DOI: 10.1007/s13277-016-4859-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
15 Waldum HL, Sagatun L, Mjønes P. Gastrin and Gastric Cancer. Front Endocrinol (Lausanne) 2017;8:1. [PMID: 28144230 DOI: 10.3389/fendo.2017.00001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
16 Levanon D, Brenner O, Otto F, Groner Y. Runx3 knockouts and stomach cancer. EMBO Rep 2003;4:560-4. [PMID: 12776174 DOI: 10.1038/sj.embor.embor868] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
17 Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2005;241:27-39. [PMID: 15621988 DOI: 10.1097/01.sla.0000149300.28588.23] [Cited by in Crossref: 405] [Cited by in F6Publishing: 348] [Article Influence: 25.3] [Reference Citation Analysis]
18 Sun DP, Fang CL, Chen HK, Wen KS, Hseu YC, Hung ST, Uen YH, Lin KY. EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer. Oncol Rep 2017;37:1953-60. [PMID: 28260059 DOI: 10.3892/or.2017.5442] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
19 Li H, Stoicov C, Cai X, Wang TC, Houghton J. Helicobacter and gastric cancer disease mechanisms: Host response and disease susceptibility. Curr Gastroenterol Rep 2003;5:459-67. [DOI: 10.1007/s11894-003-0034-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
20 Duncan SS, Valk PL, McClain MS, Shaffer CL, Metcalf JA, Bordenstein SR, Cover TL. Comparative genomic analysis of East Asian and non-Asian Helicobacter pylori strains identifies rapidly evolving genes. PLoS One. 2013;8:e55120. [PMID: 23383074 DOI: 10.1371/journal.pone.0055120] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
21 Alexander D, Yamamoto T, Kato S, Kasai S. Histopathological assessment of multidrug resistance in gastric cancer: expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein. Surg Today. 1999;29:401-406. [PMID: 10333409 DOI: 10.1007/bf02483030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
22 Choi BW, Zeon SK, Kim SH, Jo I, Kim HW, Won KS. Significance of SUV on Follow-up F-18 FDG PET at the Anastomotic Site of Gastroduodenostomy after Distal Subtotal Gastrectomy in Patients with Gastric Cancer. Nucl Med Mol Imaging 2011;45:285-90. [PMID: 24900019 DOI: 10.1007/s13139-011-0105-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
23 Chandrasekaran EV, Xue J, Piskorz C, Locke RD, Tóth K, Slocum HK, Matta KL. Potential tumor markers for human gastric cancer: an elevation of glycan:sulfotransferases and a concomitant loss of alpha1,2-fucosyltransferase activities. J Cancer Res Clin Oncol 2007;133:599-611. [PMID: 17492468 DOI: 10.1007/s00432-007-0206-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
24 Yu J, Ebert MP, Miehlke S, Rost H, Lendeckel U, Leodolter A, Stolte M, Bayerdörffer E, Malfertheiner P. alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relatives. Gut. 2000;46:639-644. [PMID: 10764706 DOI: 10.1136/gut.46.5.639] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
25 Han JY, Son H, Lee WC, Choi BG. The correlation between gastric cancer screening method and the clinicopathologic features of gastric cancer. Med Oncol. 2003;20:265-269. [PMID: 14514976 DOI: 10.1385/mo:20:3:265] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
26 Chiu PW, Chan KF, Lee YT, Sung JJ, Lau JY, Ng EK. Endoscopic submucosal dissection used for treating early neoplasia of the foregut using a combination of knives. Surg Endosc. 2008;22:777-783. [PMID: 17704882 DOI: 10.1007/s00464-007-9479-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
27 He H, Chen W, Wang X, Wang C, Liu F, Shen Z, Xu J, Gu J, Sun Y. Snail is an independent prognostic predictor for progression and patient survival of gastric cancer. Cancer Sci. 2012;103:1296-1303. [PMID: 22471696 DOI: 10.1111/j.1349-7006.2012.02295.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
28 Ebert MP, Yu J, Miehlke S, Fei G, Lendeckel U, Ridwelski K, Stolte M, Bayerdörffer E, Malfertheiner P. Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer. Br J Cancer. 2000;82:1795-1800. [PMID: 10839293 DOI: 10.1054/bjoc.1999.1107] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
29 Valetti S, Mura S, Stella B, Couvreur P. Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice. J Nanobiotechnology 2013;11 Suppl 1:S6. [PMID: 24564841 DOI: 10.1186/1477-3155-11-S1-S6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
30 Hur K, Gazdar AF, Rathi A, Jang JJ, Choi JH, Kim DY. Overexpression of human telomerase RNA in Helicobacter pylori-infected human gastric mucosa. Jpn J Cancer Res. 2000;91:1148-1153. [PMID: 11092980 DOI: 10.1111/j.1349-7006.2000.tb00898.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
31 Wang XB, Yang LT, Zhang ZW, Guo JM, Cheng XD. Pancreaticoduodenectomy for advanced gastric cancer with pancreaticoduodenal region involvement. World J Gastroenterol. 2008;14:3425-3429. [PMID: 18528942 DOI: 10.3748/wjg.14.3425] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
32 Kubicka S, Claas C, Staab S, Kühnel F, Zender L, Trautwein C, Wagner S, Rudolph KL, Manns M. p53 mutation pattern and expression of c-erbB2 and c-met in gastric cancer: relation to histological subtypes, Helicobacter pylori infection, and prognosis. Dig Dis Sci. 2002;47:114-121. [PMID: 11837710 DOI: 10.1023/a:1013275706401] [Cited by in Crossref: 41] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
33 Fang CL, Lin CC, Chen HK, Hseu YC, Hung ST, Sun DP, Uen YH, Lin KY. Ubiquitin-specific protease 3 overexpression promotes gastric carcinogenesis and is predictive of poor patient prognosis. Cancer Sci 2018;109:3438-49. [PMID: 30168892 DOI: 10.1111/cas.13789] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
34 Noda H, Miyaji Y, Nakanishi A, Konishi F, Miki Y. Frequent reduced expression of alpha-1B-adrenergic receptor caused by aberrant promoter methylation in gastric cancers. Br J Cancer. 2007;96:383-390. [PMID: 17242706 DOI: 10.1038/sj.bjc.6603555] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
35 Ozdemir NY, Abali H, Oksüzoğlu B, Budakoglu B, Uncu D, Güler T, Odabaşi H, Zengin N. The efficacy and safety of reduced-dose docetaxel, cisplatin, and 5-fluorouracil in the first-line treatment of advanced stage gastric adenocarcinoma. Med Oncol 2010;27:680-4. [PMID: 19633962 DOI: 10.1007/s12032-009-9268-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
36 Voutilainen M, Färkkilä M, Juhola M, Mecklin JP, Sipponen P. Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis. Gut. 1999;45:644-648. [PMID: 10517897 DOI: 10.1136/gut.45.5.644] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 1.7] [Reference Citation Analysis]
37 Cao Y, Liu H, Li H, Lin C, Li R, Wu S, Zhang H, He H, Zhang W, Xu J. Association of O6-Methylguanine-DNA Methyltransferase Protein Expression With Postoperative Prognosis and Adjuvant Chemotherapeutic Benefits Among Patients With Stage II or III Gastric Cancer. JAMA Surg 2017;152:e173120. [PMID: 28903131 DOI: 10.1001/jamasurg.2017.3120] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
38 Compare D, Rocco A, Nardone G. Screening for and surveillance of gastric cancer. World J Gastroenterol. 2014;20:13681-13691. [PMID: 25320506 DOI: 10.3748/wjg.v20.i38.13681] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
39 Fang CL, Uen YH, Chen HK, Hseu YC, Lin CC, Hung ST, Sun DP, Lin KY. Loss of cyclin-dependent kinase-like 2 predicts poor prognosis in gastric cancer, and its overexpression suppresses cells growth and invasion. Cancer Med 2018. [PMID: 29790675 DOI: 10.1002/cam4.1577] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
40 Wu MS, Hsieh RP, Huang SP, Chang YT, Lin MT, Chang MC, Shun CT, Sheu JC, Lin JT. Association of HLA-DQB1*0301 and HLA-DQB1*0602 with different subtypes of gastric cancer in Taiwan. Jpn J Cancer Res. 2002;93:404-410. [PMID: 11985790 DOI: 10.1111/j.1349-7006.2002.tb01271.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
41 Rajkumar T, Vijayalakshmi N, Gopal G, Sabitha K, Shirley S, Raja UM, Ramakrishnan SA. Identification and validation of genes involved in gastric tumorigenesis. Cancer Cell Int. 2010;10:45. [PMID: 21092330 DOI: 10.1186/1475-2867-10-45] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 5.1] [Reference Citation Analysis]
42 Tsugane S, Tsubono Y, Okubo S, Hayashi M, Kakizoe T. A pilot study for a randomized controlled trial to prevent gastric cancer in high-risk Japanese population: study design and feasibility evaluation. Jpn J Cancer Res 1996;87:676-9. [PMID: 8698614 DOI: 10.1111/j.1349-7006.1996.tb00276.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
43 Burns M, Amaya A, Bodi C, Ge Z, Bakthavatchalu V, Ennis K, Wang TC, Georgieff M, Fox JG. Helicobacter pylori infection and low dietary iron alter behavior, induce iron deficiency anemia, and modulate hippocampal gene expression in female C57BL/6 mice. PLoS One 2017;12:e0173108. [PMID: 28355210 DOI: 10.1371/journal.pone.0173108] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Wang YY, Li L, Zhao ZS, Wang YX, Ye ZY, Tao HQ. L1 and epithelial cell adhesion molecules associated with gastric cancer progression and prognosis in examination of specimens from 601 patients. J Exp Clin Cancer Res. 2013;32:66. [PMID: 24422715 DOI: 10.1186/1756-9966-32-66] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
45 Song K, Yang Q, Yan Y, Yu X, Xu K, Xu J. Gastric mucin phenotype indicates aggressive biological behaviour in early differentiated gastric adenocarcinomas following endoscopic treatment. Diagn Pathol 2021;16:62. [PMID: 34256780 DOI: 10.1186/s13000-021-01122-2] [Reference Citation Analysis]
46 Yang MD, Lin KC, Lu MC, Jeng LB, Hsiao CL, Yueh TC, Fu CK, Li HT, Yen ST, Lin CW, Wu CW, Pang SY, Bau DT, Tsai FJ. Contribution of matrix metalloproteinases-1 genotypes to gastric cancer susceptibility in Taiwan. Biomedicine (Taipei) 2017;7:10. [PMID: 28612708 DOI: 10.1051/bmdcn/2017070203] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
47 Rugge M, Shiao YH, Busatto G, Cassaro M, Strobbe C, Russo VM, Leo G, Parenti AR, Scapinello A, Arslan P. The p53 gene in patients under the age of 40 with gastric cancer: mutation rates are low but are associated with a cardiac location. Mol Pathol. 2000;53:207-210. [PMID: 11040944 DOI: 10.1136/mp.53.4.207] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
48 Chen BQ, Yang YM, Wang Q, Gao YH, Liu JR, Zhang JS, Wang XL, Liu RH. Effects of c9,t11-conjugated linoleic acid on adhesion of human gastric carcinoma cell line SGC-7901. World J Gastroenterol 2004;10:1392-6. [PMID: 15133841 DOI: 10.3748/wjg.v10.i10.1392] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
49 Meng CF, Zhu XJ, Peng G, Dai DQ. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines. World J Gastroenterol 2007;13:6166-71. [PMID: 18069755 DOI: 10.3748/wjg.v13.i46.6166] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
50 Gu J, Zou H, Zheng L, Li X, Chen S, Zhang L. GSTM1 null genotype is associated with increased risk of gastric cancer in both ever-smokers and non-smokers: a meta-analysis of case-control studies. Tumour Biol 2014;35:3439-45. [PMID: 24318990 DOI: 10.1007/s13277-013-1454-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
51 Chirwa N, Govender D, Ndimba B, Lotz Z, Tyler M, Panieri E, Kahn D, Mall AS. A 40-50kDa Glycoprotein Associated with Mucus is Identified as α-1-Acid Glycoprotein in Carcinoma of the Stomach. J Cancer 2012;3:83-92. [PMID: 22359529 DOI: 10.7150/jca.3737] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
52 Kano MR, Bae Y, Iwata C, Morishita Y, Yashiro M, Oka M, Fujii T, Komuro A, Kiyono K, Kaminishi M. Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling. Proc Natl Acad Sci USA. 2007;104:3460-3465. [PMID: 17307870 DOI: 10.1073/pnas.0611660104] [Cited by in Crossref: 323] [Cited by in F6Publishing: 303] [Article Influence: 23.1] [Reference Citation Analysis]
53 Chen J, Röcken C, Hoffmann J, Krüger S, Lendeckel U, Rocco A, Pastorekova S, Malfertheiner P, Ebert MP. Expression of carbonic anhydrase 9 at the invasion front of gastric cancers. Gut 2005;54:920-7. [PMID: 15951534 DOI: 10.1136/gut.2004.047340] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 4.0] [Reference Citation Analysis]
54 Olokoba AB, Obateru OA, Bojuwoye MO, Ibrahim OK, Olokoba LB. That dyspepsia in the young could be cancer. Niger Med J 2013;54:143-5. [PMID: 23798802 DOI: 10.4103/0300-1652.110053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
55 Chandanos E, Lindblad M, Jia C, Rubio CA, Ye W, Lagergren J. Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden. Br J Cancer. 2006;95:118-122. [PMID: 16755290 DOI: 10.1038/sj.bjc.6603214] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
56 Wu MS, Shun CT, Wang HP, Lee WJ, Wang TH, Lin JT. Loss of pS2 protein expression is an early event of intestinal-type gastric cancer. Jpn J Cancer Res. 1998;89:278-282. [PMID: 9600121 DOI: 10.1111/j.1349-7006.1998.tb00559.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
57 Klein S, Gildenblat J, Ihle MA, Merkelbach-Bruse S, Noh KW, Peifer M, Quaas A, Büttner R. Deep learning for sensitive detection of Helicobacter Pylori in gastric biopsies. BMC Gastroenterol 2020;20:417. [PMID: 33308189 DOI: 10.1186/s12876-020-01494-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
58 Lin SJ, Gagnon-Bartsch JA, Tan IB, Earle S, Ruff L, Pettinger K, Ylstra B, van Grieken N, Rha SY, Chung HC. Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas. Gut. 2015;64:1721-1731. [PMID: 25385008 DOI: 10.1136/gutjnl-2014-308252] [Cited by in Crossref: 127] [Cited by in F6Publishing: 108] [Article Influence: 18.1] [Reference Citation Analysis]
59 Waldum HL, Fossmark R. Types of Gastric Carcinomas. Int J Mol Sci. 2018;19. [PMID: 30567376 DOI: 10.3390/ijms19124109] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
60 Gao HJ, Yu LZ, Bai JF, Peng YS, Sun G, Zhao HL, Miu K, L XZ, Zhang XY, Zhao ZQ. Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions: H.pylori infection, histological types and staging. World J Gastroenterol. 2000;6:848-854. [PMID: 11819707 DOI: 10.3748/wjg.v6.i6.848] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 34] [Article Influence: 1.7] [Reference Citation Analysis]
61 Hayakawa Y, Jin G, Wang H, Chen X, Westphalen CB, Asfaha S, Renz BW, Ariyama H, Dubeykovskaya ZA, Takemoto Y. CCK2R identifies and regulates gastric antral stem cell states and carcinogenesis. Gut. 2015;64:544-553. [PMID: 24951258 DOI: 10.1136/gutjnl-2014-307190] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 8.7] [Reference Citation Analysis]
62 Quach DT, Hiyama T, Gotoda T. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice. World J Gastroenterol. 2019;25:3546-3562. [PMID: 31367156 DOI: 10.3748/wjg.v25.i27.3546] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
63 Hur J, Chang JH, Kim BK, Ko HY, Lee JH, Kim SJ, Song MA, Kim TH, Kim CW, Han SW. Undiagnosed Borrmann type II gastric cancer due to necrosis and regenerative epithelium. World J Gastroenterol 2014;20:9621-5. [PMID: 25071361 DOI: 10.3748/wjg.v20.i28.9621] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Li M, Wan X, Wang Y, Sun Y, Yang G, Wang L. Time trends of esophageal and gastric cancer mortality in China, 1991-2009: an age-period-cohort analysis. Sci Rep 2017;7:6797. [PMID: 28754910 DOI: 10.1038/s41598-017-07071-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
65 Dhobi MA, Wani KA, Parray FQ, Wani RA, Wani ML, Peer GQ, Abdullah S, Wani IA, Wani MA, Shah MA. Gastric cancer in young patients. Int J Surg Oncol. 2013;2013:981654. [PMID: 24381753 DOI: 10.1155/2013/981654] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
66 Zaręba KP, Zińczuk J, Dawidziuk T, Pryczynicz A, Guzińska-Ustymowicz K, Kędra B. Stomach cancer in young people - a diagnostic and therapeutic problem. Prz Gastroenterol 2019;14:283-5. [PMID: 31988675 DOI: 10.5114/pg.2019.90254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Walker LR, Erler B. Gastric cancer in the setting of persistently elevated human chorionic gonadotropin: a case report. Case Rep Obstet Gynecol 2011;2011:350318. [PMID: 22567504 DOI: 10.1155/2011/350318] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
68 Binh TT, Tuan VP, Dung HDQ, Tung PH, Tri TD, Thuan NPM, Khien VV, Hoan PQ, Suzuki R, Uchida T, Trang TTH, Yamaoka Y. Advanced non-cardia gastric cancer and Helicobacter pylori infection in Vietnam. Gut Pathog 2017;9:46. [PMID: 28824711 DOI: 10.1186/s13099-017-0195-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
69 Su M, Erwin AL, Campbell AM, Pyburn TM, Salay LE, Hanks JL, Lacy DB, Akey DL, Cover TL, Ohi MD. Cryo-EM Analysis Reveals Structural Basis of Helicobacter pylori VacA Toxin Oligomerization. J Mol Biol 2019;431:1956-65. [PMID: 30954575 DOI: 10.1016/j.jmb.2019.03.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
70 Huang CH, Chiou SH. Clinical proteomics identifies potential biomarkers in Helicobacter pylori for gastrointestinal diseases. World J Gastroenterol 2014;20:1529-36. [PMID: 24587628 DOI: 10.3748/wjg.v20.i6.1529] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
71 Khayatzadeh S, Feizi A, Saneei P, Esmaillzadeh A. Vitamin D intake, serum Vitamin D levels, and risk of gastric cancer: A systematic review and meta-analysis. J Res Med Sci 2015;20:790-6. [PMID: 26664428 DOI: 10.4103/1735-1995.168404] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
72 Kim N, Jung HC. The role of serum pepsinogen in the detection of gastric cancer. Gut Liver. 2010;4:307-319. [PMID: 20981206 DOI: 10.5009/gnl.2010.4.3.307] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
73 Ozcan S, Barkauskas DA, Renee Ruhaak L, Torres J, Cooke CL, An HJ, Hua S, Williams CC, Dimapasoc LM, Han Kim J. Serum glycan signatures of gastric cancer. Cancer Prev Res (Phila). 2014;7:226-235. [PMID: 24327722 DOI: 10.1158/1940-6207.capr-13-0235] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 4.9] [Reference Citation Analysis]
74 Bhattacharya B, Low SH, Soh C, Kamal Mustapa N, Beloueche-Babari M, Koh KX, Loh J, Soong R. Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype. Br J Pharmacol. 2014;171:3255-3267. [PMID: 24597478 DOI: 10.1111/bph.12668] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 7.3] [Reference Citation Analysis]
75 Herrera-Goepfert R, Akiba S, Koriyama C, Ding S, Reyes E, Itoh T, Minakami Y, Eizuru Y. Epstein-Barr virus-associated gastric carcinoma: Evidence of age-dependence among a Mexican population. World J Gastroenterol 2005;11:6096-103. [PMID: 16273633 DOI: 10.3748/wjg.v11.i39.6096] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
76 Johnson EM, Gaddy JA, Voss BJ, Hennig EE, Cover TL. Genes required for assembly of pili associated with the Helicobacter pylori cag type IV secretion system. Infect Immun. 2014;82:3457-3470. [PMID: 24891108 DOI: 10.1128/iai.01640-14] [Cited by in Crossref: 55] [Cited by in F6Publishing: 37] [Article Influence: 7.9] [Reference Citation Analysis]
77 Pimentel-Nunes P, Afonso L, Lopes P, Roncon-Albuquerque R, Gonçalves N, Henrique R, Moreira-Dias L, Leite-Moreira AF, Dinis-Ribeiro M. Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia. Pathol Oncol Res. 2011;17:677-683. [PMID: 21455638 DOI: 10.1007/s12253-011-9368-9] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
78 Yeh JM, Goldie SJ, Kuntz KM, Ezzati M. Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections. Cancer Causes Control. 2009;20:2021-2029. [PMID: 19642005 DOI: 10.1007/s10552-009-9397-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
79 Kim KW, Kim N, Choi Y, Kim WS, Yoon H, Shin CM, Park YS, Lee DH, Park YS, Ahn SH, Park DJ, Kim HH, Lee HS, Kim JW, Kim JW, Lee KW, Chang W, Park JH, Lee YJ, Lee KH, Kim YH. Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study. Gastric Cancer 2021;24:844-57. [PMID: 33598811 DOI: 10.1007/s10120-021-01163-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Wroblewski LE, Peek RM Jr, Coburn LA. The Role of the Microbiome in Gastrointestinal Cancer. Gastroenterol Clin North Am 2016;45:543-56. [PMID: 27546848 DOI: 10.1016/j.gtc.2016.04.010] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
81 Liang B, Wang S, Zhu XG, Yu YX, Cui ZR, Yu YZ. Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer. World J Gastroenterol. 2005;11:623-628. [PMID: 15655810 DOI: 10.3748/wjg.v11.i5.623] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
82 Byfield SA, Earle CC, Ayanian JZ, McCarthy EP. Treatment and outcomes of gastric cancer among United States-born and foreign-born Asians and Pacific Islanders. Cancer 2009;115:4595-605. [PMID: 19626648 DOI: 10.1002/cncr.24487] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
83 Fujimori Y, Inokuchi M, Takagi Y, Kato K, Kojima K, Sugihara K. Prognostic value of RKIP and p-ERK in gastric cancer. J Exp Clin Cancer Res 2012;31:30. [PMID: 22463874 DOI: 10.1186/1756-9966-31-30] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
84 Langman MJ, Dunn JA, Whiting JL, Burton A, Hallissey MT, Fielding JW, Kerr DJ. Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer. British Stomach Cancer Group. Br J Cancer 1999;81:1356-62. [PMID: 10604733 DOI: 10.1038/sj.bjc.6690457] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
85 Enzinger PC, Kulke MH, Clark JW, Ryan DP, Kim H, Earle CC, Vincitore MM, Michelini AL, Mayer RJ, Fuchs CS. A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinoma. Dig Dis Sci. 2005;50:2218-2223. [PMID: 16416165 DOI: 10.1007/s10620-005-3038-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
86 Sedda S, Marafini I, Caruso R, Pallone F, Monteleone G. Proteinase activated-receptors-associated signaling in the control of gastric cancer. World J Gastroenterol 2014;20:11977-84. [PMID: 25232234 DOI: 10.3748/wjg.v20.i34.11977] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
87 Pyburn TM, Foegeding NJ, González-Rivera C, McDonald NA, Gould KL, Cover TL, Ohi MD. Structural organization of membrane-inserted hexamers formed by Helicobacter pylori VacA toxin. Mol Microbiol 2016;102:22-36. [PMID: 27309820 DOI: 10.1111/mmi.13443] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
88 Kim BC, Jeong HO, Park D, Kim CH, Lee EK, Kim DH, Im E, Kim ND, Lee S, Yu BP, Bhak J, Chung HY. Profiling age-related epigenetic markers of stomach adenocarcinoma in young and old subjects. Cancer Inform 2015;14:47-54. [PMID: 25983541 DOI: 10.4137/CIN.S16912] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
89 Chambers MG, Pyburn TM, González-Rivera C, Collier SE, Eli I, Yip CK, Takizawa Y, Lacy DB, Cover TL, Ohi MD. Structural analysis of the oligomeric states of Helicobacter pylori VacA toxin. J Mol Biol. 2013;425:524-535. [PMID: 23178866 DOI: 10.1016/j.jmb.2012.11.020] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
90 Aoi T, Marusawa H, Sato T, Chiba T, Maruyama M. Risk of subsequent development of gastric cancer in patients with previous gastric epithelial neoplasia. Gut 2006;55:588-9. [PMID: 16531547 DOI: 10.1136/gut.2005.086884] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
91 Bae JM, Lee EJ, Guyatt G. Citrus fruit intake and stomach cancer risk: a quantitative systematic review. Gastric Cancer. 2008;11:23-32. [PMID: 18373174 DOI: 10.1007/s10120-007-0447-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
92 Wang X, Zhang H, He H, Shen Z, Tang Z, Xu J, Sun Y. Prognostic value of stromal cell-derived factor 1 expression in patients with gastric cancer after surgical resection. Cancer Sci 2014;105:1447-56. [PMID: 25220301 DOI: 10.1111/cas.12531] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
93 Winter JM, Ting AH, Vilardell F, Gallmeier E, Baylin SB, Hruban RH, Kern SE, Iacobuzio-Donahue CA. Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer. Clin Cancer Res. 2008;14:412-418. [PMID: 18223216 DOI: 10.1158/1078-0432.ccr-07-0487] [Cited by in Crossref: 108] [Cited by in F6Publishing: 54] [Article Influence: 8.3] [Reference Citation Analysis]
94 González-Domingo M, Ulloa C, Olivares J, Estrada S, González P, Cardozo N. Adjuvant radiochemotherapy in locally advanced gastric cancer: from evidence to daily clinical practice in a single institution. Ecancermedicalscience 2020;14:1137. [PMID: 33281929 DOI: 10.3332/ecancer.2020.1137] [Reference Citation Analysis]
95 Ruhaak LR, Barkauskas DA, Torres J, Cooke CL, Wu LD, Stroble C, Ozcan S, Williams CC, Camorlinga M, Rocke DM. The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer. EuPA Open Proteom. 2015;6:1-9. [PMID: 25685702 DOI: 10.1016/j.euprot.2014.11.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
96 Roder DM. The epidemiology of gastric cancer. Gastric Cancer. 2002;5 Suppl 1:5-11. [PMID: 12772880 DOI: 10.1007/s10120-002-0203-6] [Cited by in Crossref: 234] [Cited by in F6Publishing: 194] [Article Influence: 13.0] [Reference Citation Analysis]
97 Choi J, Lim H, Nam DK, Kim HS, Cho DY, Yi JW, Kim HC, Cho YK, Kim MW, Joo HJ, Lee KB, Kim KB. Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection. Br J Cancer 2001;84:186-92. [PMID: 11161374 DOI: 10.1054/bjoc.2000.1553] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
98 Burns M, Muthupalani S, Ge Z, Wang TC, Bakthavatchalu V, Cunningham C, Ennis K, Georgieff M, Fox JG. Helicobacter pylori Infection Induces Anemia, Depletes Serum Iron Storage, and Alters Local Iron-Related and Adult Brain Gene Expression in Male INS-GAS Mice. PLoS One 2015;10:e0142630. [PMID: 26575645 DOI: 10.1371/journal.pone.0142630] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
99 Cao Y, Liu H, Zhang H, Lin C, Li R, Wu S, Li H, He H, Zhang W, Xu J. CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients. Oncotarget 2017;8:20328-39. [PMID: 27780937 DOI: 10.18632/oncotarget.12815] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
100 Allum WH, Griffin SM, Watson A, Colin-Jones D; Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland., British Society of Gastroenterology., British Association of Surgical Oncology. Guidelines for the management of oesophageal and gastric cancer. Gut 2002;50 Suppl 5:v1-23. [PMID: 12049068 DOI: 10.1136/gut.50.90005.v1] [Cited by in F6Publishing: 42] [Reference Citation Analysis]
101 Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23:713-739. [PMID: 20930071 DOI: 10.1128/cmr.00011-10] [Cited by in Crossref: 680] [Cited by in F6Publishing: 348] [Article Influence: 61.8] [Reference Citation Analysis]
102 Li S, Fan T, Liu H, Chen J, Qin C, Ren X. Tumor suppressor ING4 overexpression contributes to proliferation and invasion inhibition in gastric carcinoma by suppressing the NF-κB signaling pathway. Mol Biol Rep 2013;40:5723-32. [PMID: 24057236 DOI: 10.1007/s11033-013-2675-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
103 Shan YS, Hsu HP, Lai MD, Yen MC, Chen WC, Fang JH, Weng TY, Chen YL. Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines. Sci Rep 2015;5:9783. [PMID: 25928182 DOI: 10.1038/srep09783] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
104 Gharouni M, Abouzari M, Rashidi A, Sodagari N, Behzadi M. Low frequency of blood group A in primary central nervous system lymphoma. J Neurooncol 2008;87:363-4. [PMID: 18209953 DOI: 10.1007/s11060-008-9516-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
105 Huang P, Li S, Aronow WS, Wang Z, Nair CK, Xue N, Shen X, Chen C, Cosgrove D. Double contrast-enhanced ultrasonography evaluation of preoperative Lauren classification of advanced gastric carcinoma. Arch Med Sci. 2011;7:287-293. [PMID: 22291769 DOI: 10.5114/aoms.2011.22080] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
106 Deng J, Liang H, Sun D, Zhang R, Zhan H, Wang X. Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence. Can J Gastroenterol. 2008;22:835-839. [PMID: 18925308 DOI: 10.1155/2008/761821] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
107 Osaki M, Inoue T, Yamaguchi S, Inaba A, Tokuyasu N, Jeang KT, Oshimura M, Ito H. MAD1 (mitotic arrest deficiency 1) is a candidate for a tumor suppressor gene in human stomach. Virchows Arch. 2007;451:771-779. [PMID: 17674037 DOI: 10.1007/s00428-007-0470-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
108 Cover TL, Peek RM. Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer. Gut Microbes. 2013;4:482-493. [PMID: 23989802 DOI: 10.4161/gmic.26262] [Cited by in Crossref: 60] [Cited by in F6Publishing: 45] [Article Influence: 7.5] [Reference Citation Analysis]
109 Park MJ, Kim DH, Lim SH, Yim JY, Kim YS, Cho KR, Kim CH, Jung HC, Song IS, Kim SS, Yoon DH, Shin CS, Cho SH, Oh BH, Lee DH. Features of Gastric Neoplasm Detected during the Screening Examination. Gut Liver 2007;1:33-9. [PMID: 20485656 DOI: 10.5009/gnl.2007.1.1.33] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
110 Fang CL, Hseu YC, Lin YF, Hung ST, Tai C, Uen YH, Lin KY. Clinical and prognostic association of transcription factor SOX4 in gastric cancer. PLoS One 2012;7:e52804. [PMID: 23285187 DOI: 10.1371/journal.pone.0052804] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
111 Song HJ, Shim KN, Joo YH, Kim SE, Jung SA, Yoo K. Methylation of the Tumor Suppressor Gene RUNX3 in Human Gastric Carcinoma. Gut Liver 2008;2:119-25. [PMID: 20485621 DOI: 10.5009/gnl.2008.2.2.119] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
112 Bani-Hani KE, Yaghan RJ, Heis HA, Shatnawi NJ, Matalka II, Bani-Hani AM, Gharaibeh KA. Gastric malignancies in Northern Jordan with special emphasis on descriptive epidemiology. World J Gastroenterol 2004;10:2174-8. [PMID: 15259060 DOI: 10.3748/wjg.v10.i15.2174] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
113 Yang MD, Wang HC, Chang WS, Tsai CW, Bau DT. Genetic polymorphisms of DNA double strand break gene Ku70 and gastric cancer in Taiwan. BMC Cancer 2011;11:174. [PMID: 21575261 DOI: 10.1186/1471-2407-11-174] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
114 Cravo M, Pinto R, Fidalgo P, Chaves P, Glória L, Nobre-Leitão C, Costa Mira F. Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma. Gut 1996;39:434-8. [PMID: 8949650 DOI: 10.1136/gut.39.3.434] [Cited by in Crossref: 80] [Cited by in F6Publishing: 62] [Article Influence: 3.3] [Reference Citation Analysis]
115 Lindblad M, García Rodríguez LA, Chandanos E, Lagergren J. Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer 2006;94:136-41. [PMID: 16404367 DOI: 10.1038/sj.bjc.6602906] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 4.2] [Reference Citation Analysis]
116 Wu MS, Lin YS, Chang YT, Shun CT, Lin MT, Lin JT. Gene expression profiling of gastric cancer by microarray combined with laser capture microdissection. World J Gastroenterol 2005;11:7405-12. [PMID: 16437709 DOI: 10.3748/wjg.v11.i47.7405] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
117 Raab R, Sparano JA, Ocean AJ, Christos P, Ramirez M, Vinciguerra V, Kaubisch A. A phase I trial of oblimersen sodium in combination with cisplatin and 5-fluorouracil in patients with advanced esophageal, gastroesophageal junction, and gastric carcinoma. Am J Clin Oncol 2010;33:61-5. [PMID: 19738454 DOI: 10.1097/COC.0b013e3181a31ad0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
118 Kang G, Hwang WC, Do IG, Wang K, Kang SY, Lee J, Park SH, Park JO, Kang WK, Jang J, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Kim MJ, Kim S, Park CK, Kim KM. Exome sequencing identifies early gastric carcinoma as an early stage of advanced gastric cancer. PLoS One 2013;8:e82770. [PMID: 24376576 DOI: 10.1371/journal.pone.0082770] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
119 Yaghoobi M, Rakhshani N, Sadr F, Bijarchi R, Joshaghani Y, Mohammadkhani A, Attari A, Akbari MR, Hormazdi M, Malekzadeh R. Hereditary risk factors for the development of gastric cancer in younger patients. BMC Gastroenterol 2004;4:28. [PMID: 15509297 DOI: 10.1186/1471-230X-4-28] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
120 Silva EM, Begnami MD, Fregnani JH, Pelosof AG, Zitron C, Montagnini AL, Soares FA. Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma. Gastric Cancer 2008;11:149-59. [PMID: 18825309 DOI: 10.1007/s10120-008-0468-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
121 Li JH, Shi XZ, Lv S, Liu M, Xu GW. Effect of Helicobacter pylori infection on p53 expression of gastric mucosa and adenocarcinoma with microsatellite instability. World J Gastroenterol 2005;11:4363-6. [PMID: 16038035 DOI: 10.3748/wjg.v11.i28.4363] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
122 Hirano A, Yanai H, Shimizu N, Okamoto T, Matsubara Y, Yamamoto K, Okita K. Evaluation of epstein-barr virus DNA load in gastric mucosa with chronic atrophic gastritis using a real-time quantitative PCR assay. Int J Gastrointest Cancer. 2003;34:87-94. [PMID: 15361640 DOI: 10.1385/IJGC:34:2-3:087] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
123 Choi JH, Lim HY, Joo HJ, Kim HS, Yi JW, Kim HC, Cho YK, Kim MW, Lee KB. Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection. Br J Cancer. 2002;86:1578-1585. [PMID: 12085207 DOI: 10.1038/sj.bjc.6600305] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
124 Moon CM, Kim SH, Lee SK, Hyeon J, Koo JS, Lee S, Wang JS, Huh WJ, Khurana SS, Mills JC. Chronic tamoxifen use is associated with a decreased risk of intestinal metaplasia in human gastric epithelium. Dig Dis Sci. 2014;59:1244-1254. [PMID: 24368421 DOI: 10.1007/s10620-013-2994-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
125 Zullo A, Hassan C, Romiti A, Giusto M, Guerriero C, Lorenzetti R, Campo SM, Tomao S. Follow-up of intestinal metaplasia in the stomach: When, how and why. World J Gastrointest Oncol. 2012;4:30-36. [PMID: 22468181 DOI: 10.4251/wjgo.v4.i3.30] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
126 el-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut. 1998;43:327-333. [PMID: 9863476 DOI: 10.1136/gut.43.3.327] [Cited by in Crossref: 247] [Cited by in F6Publishing: 220] [Article Influence: 10.7] [Reference Citation Analysis]
127 Abouzari M, Behzadi M, Rashidi A. Low frequency of blood group A in secondary central nervous system lymphoma. Surg Neurol Int 2012;3:95. [PMID: 23050209 DOI: 10.4103/2152-7806.100179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
128 Castaño-Rodríguez N, Kaakoush NO, Mitchell HM. Pattern-recognition receptors and gastric cancer. Front Immunol 2014;5:336. [PMID: 25101079 DOI: 10.3389/fimmu.2014.00336] [Cited by in Crossref: 17] [Cited by in F6Publishing: 43] [Article Influence: 2.4] [Reference Citation Analysis]
129 Lee I, Lee H, Kim M, Fukumoto M, Sawada S, Jakate S, Gould VE. Ethnic difference of Helicobacter pylori gastritis: Korean and Japanese gastritis is characterized by male- and antrum-predominant acute foveolitis in comparison with American gastritis. World J Gastroenterol. 2005;11:94-98. [PMID: 15609404 DOI: 10.3748/wjg.v11.i1.94] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
130 Vasas P, Wiggins T, Chaudry A, Bryant C, Hughes FS. Emergency presentation of the gastric cancer; prognosis and implications for service planning. World J Emerg Surg 2012;7:31. [PMID: 23009085 DOI: 10.1186/1749-7922-7-31] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
131 Mjønes P, Nordrum IS, Sørdal Ø, Sagatun L, Fossmark R, Sandvik A, Waldum HL. Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells. Horm Cancer 2018;9:40-54. [PMID: 28980157 DOI: 10.1007/s12672-017-0311-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
132 Qiu M, Yang D, Xu R. Impact of marital status on survival of gastric adenocarcinoma patients: Results from the Surveillance Epidemiology and End Results (SEER) Database. Sci Rep 2016;6:21098. [PMID: 26876653 DOI: 10.1038/srep21098] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]